The Anti-Glomerular Basement Membrane (Anti-GBM) Antibody Test detects autoantibodies against the glomerular basement membrane (GBM) in the kidneys. It is primarily used to diagnose Goodpasture Syndrome, a rare autoimmune disease that affects the kidneys and lungs, and to differentiate it from other causes of rapidly progressive glomerulonephritis (RPGN).
✅ To Diagnose Goodpasture Syndrome
✅ To Identify the Cause of Rapidly Progressive Glomerulonephritis (RPGN)
✅ To Monitor Disease Activity & Treatment Response
🩸 Blood Sample Collection:
| Result | Value (U/mL) | Interpretation |
|---|---|---|
| Negative | < 20 U/mL | No significant Anti-GBM antibodies detected |
| Borderline | 20 – 40 U/mL | Possible early autoimmune activity (requires follow-up) |
| Positive | > 40 U/mL | Strongly suggests Goodpasture Syndrome or RPGN |
🔹 Higher levels indicate active autoimmune attack on the kidneys and/or lungs.
🔹 A negative result does not completely rule out disease; additional testing may be needed.
🔴 Positive Anti-GBM Antibodies (> 40 U/mL) Suggest:
🟢 Negative Anti-GBM Antibodies (< 20 U/mL):
🔬 Further Tests to Confirm Diagnosis:
✅ Treatment for Goodpasture Syndrome / Anti-GBM Disease:
🔹 Anti-GBM antibodies are highly specific for Goodpasture Syndrome and RPGN.
🔹 A positive test requires urgent follow-up to prevent kidney failure.
🔹 Early treatment improves prognosis and may prevent permanent kidney damage.
🔹 A kidney biopsy is often needed for confirmation.
₹2,999.00 Original price was: ₹2,999.00.₹1,299.00Current price is: ₹1,299.00.